Cost-effectiveness of exercise therapy added to general practitioner care for osteoarthritis of the hip.

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON28773

Enrollment

210

Registered

2008-09-26

Start date

2009-02-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

oefentherapie, fysiotherapie, heup, artrose, huisarts, exercise therapy, hip, osteoarthritis, physical therapy, general practitioner.

Interventions

Intervention group: Fifteen consultations for exercise therapy will be prescribed and content, intensity, and frequency of treatment will be tailored to the patient’s needs. A maximum of 12 sessions

Eligibility

Inclusion criteria

Inclusion criteria: Patients will be eligible for inclusion in this trial if they: 1. Consult the GP for a new episode of non-traumatic hip complaints. 2. Are 45 years or older. 3. Comply with the clinical American College of Rheumatology (ACR) criteria for hip OA. 4. Complete the informed consent procedure.

Exclusion criteria

Exclusion criteria: Patients will be excluded if they: 1. Are already treated with exercise therapy in the present episode of hip OA. 2. Have hip pain score of <2 on numeric rating score (0-10 scale). 3. Have a high level of physical function, a score of <2 on the walking ability and the physical function sections of the Algofunctional index. 4. Have undergone hip surgery or those on the waiting list for surgery. 5. Have severe disabling co-morbidity.

Design outcomes

Primary

Measure	Time frame
Hip pain and hip function measured with the Hip Osteoarthritis disability Outcome Score (HOOS).	—

Secondary

Measure	Time frame
- Hip pain, Numeric Rating Scale score (NRS; 0-10 scale). - Walking ability, 5-meter walking test (time in seconds). - Functional mobility, timed Up and Go test. - Perceived recovery (7-point Likert scale). - Costs, EuroQol (EQ-5D) for the cost utility analysis and all direct medical and patient costs (TIC-P Questionnaire) and indirect costs (PRODISQ), such as referral to the orthopaedic specialist and subsequent treatment, including surgery. Other parameters: · Demographic data (including age, gender, height, weight, education, duration of complaints, previous hip pain, co-morbidity, scores from X-ray). · Physical examination. · Compliance to assigned treatment and implementation of home exercises. · Co-interventions, including referral to physical therapy in the control group.	—

Measure

Time frame

- Hip pain, Numeric Rating Scale score (NRS; 0-10 scale). - Walking ability, 5-meter walking test (time in seconds). - Functional mobility, timed Up and Go test. - Perceived recovery (7-point Likert scale). - Costs, EuroQol (EQ-5D) for the cost utility analysis and all direct medical and patient costs (TIC-P Questionnaire) and indirect costs (PRODISQ), such as referral to the orthopaedic specialist and subsequent treatment, including surgery. Other parameters: · Demographic data (including age, gender, height, weight, education, duration of complaints, previous hip pain, co-morbidity, scores from X-ray). · Physical examination. · Compliance to assigned treatment and implementation of home exercises. · Co-interventions, including referral to physical therapy in the control group.

—

Contacts

Public ContactP.A.J. Luijsterburg

Erasmus Medical Center Department of General Practice Room NA1905 PO Box 2040

p.luijsterburg@erasmusmc.nl+31 10 7037513

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)